top of page
Search
IN VITRO REVOLUTION
Alzheimer's Disease
Idiopathic Pulmonary Fibrosis
Congenital Heart Disease
Type 1 Diabetes Mellitus
Inflammatory Bowel Disease
Amyotrophic Lateral Sclerosis
Thrombocytopenia
Chronic Skin Wounds
INDUSTRY NEWS
Product Launches
Intra-industry Partnerships
M&A Activity
Grants Awarded & Funds Raised
Pharma & Biotech Collaborations
Clinical Trial Authorizations
Regulatory Modernization
TECH FRONTIERS
APPLICATION EXPLORER
Log In
Subscribe to Newsletter
All Posts
Organ-on-a-chip systems
Intra-industry partnerships
Pharma & biotech collaborations
Product Launches
Clinical Trial Outcomes
M&A Activity
Bioprinting
3D tissue platforms
Clinical Trial Authorizations
Regulatory Modernizations
Organoid technologies
Grants Awarded & Funds Raised
Hybrid AI-in vitro platforms
Inventia Life Science launches RASTRUM Validated Solutions to accelerate decision-grade data
Product Launches
Adaptive and context-aware volumetric printing enhances functional relevance of 3D bioprinted human tissues
Bioprinting
Prellis Biologics joins forces with Eli Lilly to transform how target-specific human antibodies are generated
Pharma & biotech collaborations
UMC Utrecht receives €2.3M grant to advance its generative, context-aware 3D bioprinting method
Grants Awarded & Funds Raised
Inventia Life Science's bioprinted ovarian cancer model opens door for HMRI's efavirenz repurposing
Clinical Trial Authorizations
bottom of page